We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

8 hedge funds and large institutions have $7.2M invested in Altamira Therapeutics Ltd in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

14% more funds holding

Funds holding: 7 → 8 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

24% less capital invested

Capital invested by funds: $9.5M → $7.2M (-$2.3M)

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$272K
2
VF
Virtu Financial
New York
+$163K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$54.4K

Top Sellers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
-$90K
2
ARTA
A.R.T. Advisors
New York
-$16K
3
Citadel Advisors
Citadel Advisors
Florida
-$15K
4
KeyBank National Association
KeyBank National Association
Ohio
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
SMV
1
Sofinnova Management VIII
California
$4.62M – – –
BG
2
Bellevue Group
Switzerland
$1.28M – – –
Morgan Stanley
3
Morgan Stanley
New York
$584K +$272K +5 +71%
TCM
4
Tekla Capital Management
Massachusetts
$457K – – –
VF
5
Virtu Financial
New York
$129K +$163K +3 New
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$33K +$54.4K +1 New
SPC
7
Sigma Planning Corp
Michigan
$32K – – –
WS
8
Wedbush Securities
California
$26K – – –
TSS
9
Two Sigma Securities
New York
$14K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$9K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$7K – – –
BTS
12
BB&T Securities
Virginia
$6K – – –
CG
13
Cutler Group
California
$2K – – –
WA
14
Wasatch Advisors
Utah
– -$90K -1 Closed
ARTA
15
A.R.T. Advisors
New York
– -$16K – –
Citadel Advisors
16
Citadel Advisors
Florida
– -$15K – –
KeyBank National Association
17
KeyBank National Association
Ohio
– -$14K – –

CYTO Hedge Fund Activity: Q4 2017 in Review

8 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q4 2017, worth a combined $7.2M — down 24% from $9.5M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CYTO positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $272K. The largest seller was Wasatch Advisors, exiting entirely with an estimated $90K sold.

  • 8 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q4 2017, up from 7 in Q3 2017.
  • Funds reported $7.2M of Altamira Therapeutics Ltd stock for Q4 2017, down 24% quarter-over-quarter.
  • 2 funds opened new Altamira Therapeutics Ltd positions in Q4 2017 and 1 closed out, a net change of +1 holder.
  • The largest Altamira Therapeutics Ltd buyer in Q4 2017 was Morgan Stanley, an estimated $272K added.
  • The largest Altamira Therapeutics Ltd seller in Q4 2017 was Wasatch Advisors, an estimated $90K sold.

Based on aggregated 13F filings for Q4 2017.